DE3784743T2 - Hydroxamsaeuren. - Google Patents
Hydroxamsaeuren.Info
- Publication number
- DE3784743T2 DE3784743T2 DE8787300366T DE3784743T DE3784743T2 DE 3784743 T2 DE3784743 T2 DE 3784743T2 DE 8787300366 T DE8787300366 T DE 8787300366T DE 3784743 T DE3784743 T DE 3784743T DE 3784743 T2 DE3784743 T2 DE 3784743T2
- Authority
- DE
- Germany
- Prior art keywords
- hydroxamic acids
- acids
- formula
- amino acid
- acid residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868601368A GB8601368D0 (en) | 1986-01-21 | 1986-01-21 | Hydroxamic acids |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3784743D1 DE3784743D1 (en) | 1993-04-22 |
DE3784743T2 true DE3784743T2 (de) | 1993-06-24 |
Family
ID=10591684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8787300366T Expired - Lifetime DE3784743T2 (de) | 1986-01-21 | 1987-01-16 | Hydroxamsaeuren. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0231081B1 (de) |
JP (1) | JP2532859B2 (de) |
AT (1) | ATE87005T1 (de) |
DE (1) | DE3784743T2 (de) |
ES (1) | ES2053525T3 (de) |
GB (1) | GB8601368D0 (de) |
GR (1) | GR3007389T3 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0455818A4 (en) * | 1989-11-24 | 1993-05-12 | Banyu Pharmaceutical Co., Ltd. | Physiologically active substance be-16627 |
GB9211706D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
GB9211707D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
AU666727B2 (en) * | 1992-06-25 | 1996-02-22 | F. Hoffmann-La Roche Ag | Hydroxamic acid derivatives |
GB9213473D0 (en) * | 1992-06-25 | 1992-08-12 | Hoffmann La Roche | Hydroxamic acid derivatives |
US5594106A (en) * | 1993-08-23 | 1997-01-14 | Immunex Corporation | Inhibitors of TNF-α secretion |
GB9411088D0 (en) * | 1994-06-03 | 1994-07-27 | Hoffmann La Roche | Hydroxylamine derivatives |
GB9423914D0 (en) * | 1994-11-26 | 1995-01-11 | British Biotech Pharm | Polyether derivatives as metalloproteinase inhibitors |
US5639746A (en) * | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
US5672598A (en) * | 1995-03-21 | 1997-09-30 | The Procter & Gamble Company | Lactam-containing hydroxamic acids |
US5917090A (en) * | 1995-06-30 | 1999-06-29 | British Biotech Pharmaceuticals Ltd. | Matrix metalloproteinase inhibitors |
BR9712085A (pt) | 1996-08-28 | 2000-10-24 | Procter & Gamble | Inibidores de metaloprotease heterocìclicos |
CA2264254C (en) * | 1996-08-28 | 2003-03-11 | Yetunde Olabisi Taiwo | Phosphinic acid amides as matrix metalloprotease inhibitors |
WO1998008825A1 (en) * | 1996-08-28 | 1998-03-05 | The Procter & Gamble Company | 1,4-heterocyclic metalloprotease inhibitors |
PL331920A1 (en) * | 1996-08-28 | 1999-08-16 | Procter & Gamble | Spirocyclic inhibitors of metaloproteases |
BR9713186A (pt) * | 1996-08-28 | 1999-11-03 | Procter & Gamble | Inibidores de metaloprotease 1,3-diheterocìclicos |
US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
CA2265666C (en) | 1996-09-10 | 2008-01-15 | British Biotech Pharmaceuticals Limited | Cytostatic hydroxamic acid derivatives |
KR100352316B1 (ko) | 1997-07-31 | 2002-09-12 | 더 프록터 앤드 갬블 캄파니 | 메탈로프로테아제억제제로서사용되는술포닐아미노치환히드록삼산유도체 |
KR20010102486A (ko) | 1999-03-03 | 2001-11-15 | 데이비드 엠 모이어 | 알케닐- 및 알키닐-함유 메탈로프로테아제 저해제 |
AU2001271068A1 (en) * | 2000-07-18 | 2002-01-30 | Chugai Seiyaku Kabushiki Kaisha | Matrix metalloprotease inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2518088B1 (fr) * | 1981-12-16 | 1987-11-27 | Roques Bernard | Nouveaux derives d'aminoacides, et leur application therapeutique |
US4599361A (en) * | 1985-09-10 | 1986-07-08 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
-
1986
- 1986-01-21 GB GB868601368A patent/GB8601368D0/en active Pending
-
1987
- 1987-01-16 ES ES87300366T patent/ES2053525T3/es not_active Expired - Lifetime
- 1987-01-16 EP EP87300366A patent/EP0231081B1/de not_active Expired - Lifetime
- 1987-01-16 DE DE8787300366T patent/DE3784743T2/de not_active Expired - Lifetime
- 1987-01-16 AT AT87300366T patent/ATE87005T1/de not_active IP Right Cessation
- 1987-01-20 JP JP62009207A patent/JP2532859B2/ja not_active Expired - Lifetime
-
1993
- 1993-03-18 GR GR920402603T patent/GR3007389T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0231081A2 (de) | 1987-08-05 |
ATE87005T1 (de) | 1993-04-15 |
GR3007389T3 (de) | 1993-07-30 |
ES2053525T3 (es) | 1994-08-01 |
EP0231081A3 (en) | 1989-11-15 |
JPS62228097A (ja) | 1987-10-06 |
EP0231081B1 (de) | 1993-03-17 |
JP2532859B2 (ja) | 1996-09-11 |
DE3784743D1 (en) | 1993-04-22 |
GB8601368D0 (en) | 1986-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2053525T3 (es) | Acidos hidroxamicos. | |
DZ1405A1 (fr) | Dérivés de n-(3-hydroxy-4-piperidinyl)(dihydro-benzofuranne, dihydro-2h-benzopy-ranne ou dishydro-benzodioxin)carboxamide. | |
NL300283I1 (nl) | Alfa- en bèta-aminozuur-hydroxyethylamino-sulfonamiden die toepasbaar zijn als retrovirale-prothease-remmers. | |
FI850078A0 (fi) | N-(4-piperidinyl)-bicykliska -kondenserade 2-imidazolaminderivat. | |
BR9305162A (pt) | Composto, formulação farmacêutica e processo para a preparação de um composto | |
LV5738A4 (lv) | Aminoskabju atvasinajumi | |
DK0412404T3 (da) | Thiazolderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater omfattende derivaterne | |
PT88577A (pt) | Process for the manufacture of novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides | |
ES8305695A1 (es) | Procedimiento para preparar derivados de amidas. | |
BR9305164A (pt) | Composto, formulação farmacêutica e processo para preparar um composto | |
AU590172B2 (en) | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof | |
ATE48001T1 (de) | Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate. | |
NO894349D0 (no) | Tienopyridin-type mevalonolaktoner. | |
FR2558837B1 (fr) | Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant | |
AU3895689A (en) | Cyclic sulfur-containing amino acid derivatives | |
PH21632A (en) | Process for preparing n-substituted amido amino acid | |
ES2054989T3 (es) | Derivados de aminodiol inhibidores de renina. | |
ATE46347T1 (de) | Immunostimulierende peptide. | |
DK1098901T3 (da) | Nye 6-deoxyerythromycinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler | |
ZA9610804B (en) | 4-Imidazolidinone compound process for its preparation and the pharmaceutical compositions which contain it | |
DE3587915D1 (de) | Verfahren zur Herstellung von Cephalosporinen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |